Skip to content
Search

Latest Stories

Coronavirus: Government announces £20m fund for vaccine research, launches public health campaign

Amid concerns over the ongoing novel coronavirus outbreak, the government has pledged £20m to develop new vaccines to combat the world’s deadliest diseases.

The new funding announced today will go to the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership between public, private, philanthropic, and civil society organisations launched in 2017 in response to the Ebola epidemic in West Africa.


It will support the development of new vaccines for epidemics including the novel coronavirus.

Health Secretary Matt Hancock said: “Vaccines are our best defence against a host of deadly diseases including coronavirus. The UK is a hub of world-leading and pioneering research, and it is vital that we lead the way in developing new vaccines to target global threats with scientists from across the world.”

“The £20 million announced today will help our globally recognised vaccine development capabilities continue to develop new defences against emerging diseases including coronavirus,” he said.

https://twitter.com/MattHancock/status/1224275091934060544

Welcoming the UK’s support and funding, CEPI said the rapid global spread and unique epidemiological characteristics of the virus were deeply concerning.

“Our hope is that, with our partners, we can get an investigational vaccine from gene sequencing of the pathogen through to clinical testing in 16 weeks. The earliest stage of clinical trials (Phase I), to establish the safety of investigational vaccines, would take around two to four months,” CEPI CEO Dr Richard Hatchett said.

Nation-wide campaign

The Department of Health and Social Care (DHSC) also launched a UK-wide campaign to provide clear advice to the public on how slow the spread of Coronavirus and reduce the impact on NHS services.

While two cases of Coronavirus have already been confirmed in the UK, the Health Secretary further assured that the NHS is well prepared to manage these types of incidents.

Similar to the 'Catch it, Bin it, Kill it' campaign used for flu and norovirus, the latest campaign will also promote important hygiene practices, such as regularly washing hands and always sneezing into a tissue, to stem the spread of viruses.

“Lots of people are asking what they can do to help stop the spread of the virus. Basic hygiene such as washing our hands regularly and using tissues when we cough and sneeze can play an important role in minimising the spread of viruses like this. Today we have launched a UK-wide advertising campaign to help the public protect themselves and each other," Hancock said in a separate statement.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less